The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiat

The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiat

Item

http://www.wikidata.org/entity/Q34505900

Q34505900

about

Topical treatments for scalp psoriasis The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings Circulating Th17, Th22, and Th1 cells are increased in psoriasis Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris Immunology of psoriasis Putting together the psoriasis puzzle: an update on developing targeted therapies Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis Cytokines in psoriasis Construction, purification, and characterization of a chimeric TH1 antagonist.The immunologic effects of estrogen on psoriasis: A comprehensive review.Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis.Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions.Hypercholesterolemia and risk of incident psoriasis and psoriatic arthritis in US women A Sleeping Beauty DNA transposon-based genetic sensor for functional screening of vitamin D3 analogues Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions.Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis.An epidemiological study on trigger factors and quality of life in psoriatic patients New insights of T cells in the pathogenesis of psoriasis Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis.Serum levels of LL-37 and inflammatory cytokines in plaque and guttate psoriasis.Skin immune sentinels in health and disease.Calcineurin inhibitors suppress cytokine production from memory T cells and differentiation of naïve T cells into cytokine-producing mature T cells.Hypertension, antihypertensive medication use, and risk of psoriasis.Development of a bioengineered skin-humanized mouse model for psoriasis: dissecting epidermal-lymphocyte interacting pathways.Effects of monomethylfumarate on dendritic cell differentiation.XP-828L (Dermylex), a new whey protein extract with potential benefit for mild to moderate psoriasis.Selective targeting of T cell subsets: focus on alefacept - a remittive therapy for psoriasis.Novel immune-based therapies for psoriasis.Perspectives for TNF-alpha-targeting therapies.Emerging role of anti-tumor necrosis factor therapy in rheumatic diseases Genetic Epidemiology of Psoriasis The role of T cells in psoriasis.Cytokine and anticytokine therapy in dermatology.Evolution of biologic therapies for the treatment of psoriasis.Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial.IL-22/STAT3-Induced Increases in SLURP1 Expression within Psoriatic Lesions Exerts Antimicrobial Effects against Staphylococcus aureus.Enhancement of anti-murine colon cancer immunity by fusion of a SARS fragment to a low-immunogenic carcinoembryonic antigen.Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasis.Use of Kv1.3 blockers for inflammatory skin conditions.

P2860

Q24186104-091BE6A5-0791-400E-BB02-DA2088577014 Q24623195-D3A568F7-141F-4380-BF26-91BF0B93A036 Q24629315-77129829-DF08-45B1-80DB-CE6C7B5F8224 Q24676186-96118893-827A-4F41-ADC4-C95F3E60654B Q26995800-4600D57F-3A59-4FE8-88D8-0E41105665D9 Q27026785-91955895-D270-476D-AFF8-9412B4FF25BD Q27693878-2FBC7BB5-3FDF-44C7-8B0D-A03D872FB470 Q28255491-A8E8CE58-5460-45D2-A811-391B4F18AB4A Q33244262-CAA06EEF-CADB-4CD5-BB7C-F0F1915D4B5C Q33640627-CC00474C-16ED-406C-8C3E-D3A064BDB159 Q33757065-53504645-A9D2-4697-9671-63AFC6BFA247 Q33760897-D6508BE2-83E3-4AA7-85B5-E64AE8765693 Q33795308-734F59D7-1748-4FE7-BEF7-4F43700DC509 Q33848992-1670246C-4312-4DCB-B448-1A4DED9619B0 Q33865243-6D647865-B1F4-42EA-A88B-972E41A0BF7A Q33902313-F7C98434-0914-4935-9DE3-E964D4C6042F Q33941199-F8B2D203-3034-4C2B-B118-3FF63F80D56C Q34035874-0F1FC709-A5F9-4C05-B63A-3FF57B777A8E Q34043846-E7E7A27F-F955-40EC-ADFE-59A9A2E46CBB Q34091087-57B9A599-2342-4AF6-B3FC-CF79C347F415 Q34114368-358EF629-054D-4F97-9CE7-8948A3276317 Q34165173-073E5EE5-7C75-4A59-91DC-2EC5D76B0DDC Q34168242-2702CA23-A666-42E7-B1ED-7BBB83B80715 Q34285159-EBD0F907-9D53-4AB1-9E15-B773F8F0A164 Q34358442-CA328863-321F-4030-ABA1-B1229A0DD68A Q34564447-47E1EAD1-074A-4812-96A1-896737F6E4B4 Q34585886-C01E075A-26B5-4EFB-AE92-ADAAE56E2E4D Q34602577-DF44FF84-0948-4B40-9262-4EF65A6AE3CC Q34609477-97951515-65A5-4403-A67E-A0814604FEBA Q34731078-161A65B7-C7C0-4CD0-8398-7096498FB272 Q34731307-3BAF72CA-19FA-409F-9386-DCBD559FC367 Q34845927-56018673-7BC4-4BFF-AFCA-25871A7937C2 Q35110104-B6265A38-258F-4524-AE9E-0FC49F7EDC32 Q35184711-6E9D7DC9-76F6-4582-AB89-0E611E4B766F Q35606903-85EAB1F0-6552-45AB-BAB3-327EC8C61B76 Q35760193-ADCE28BF-8B16-4BBB-A3E8-9553C5C7B8EB Q35810626-17666926-104D-4795-A3BC-8668F533C6E0 Q35819268-39640190-F7C7-49FD-B891-79367833C63D Q35868862-3ABC47F0-EEED-4D13-9812-33F118890ABB Q35915882-43A36DE0-6212-4019-BDC5-38A7E2CE671A

P2860

The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiat

Item

http://www.wikidata.org/entity/Q34505900

description

1999 nî lūn-bûn

@nan

1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu